Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...

In a large U.S. retrospective cohort study published in JAMA Network Open, investigators report that glucagon-like peptide-1 ...

The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...

Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore ‌a shift ​to approaching the brain-wasting disease as a system of ...

Blood and genetic tests to accurately identify biomarkers of the disease are becoming available, but most diagnoses require a ...

About one in eight American adults say they’ve used a GLP-1 receptor agonist medication like Ozempic or Wegovy at some point, ...

Research last month suggested that starting GLP-1 receptor agonist treatment in people with epilepsy and type 2 diabetes was associated with reduced risks of seizure recurrence, hospitalization, and ...

Experts warn that while ACV may offer minor metabolic effects, effective weight management requires comprehensive lifestyle ...

Many surgeons recommend giving up smoking, alcohol, or drugs before surgery, but researchers have found this may also ...

Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk in individuals with schizophrenia spectrum disorders compared with placebo.